166 related articles for article (PubMed ID: 32941064)
1. Cost of Tuberculosis Therapy Directly Observed on Video for Health Departments and Patients in New York City; San Francisco, California; and Rhode Island (2017-2018).
Beeler Asay GR; Lam CK; Stewart B; Mangan JM; Romo L; Marks SM; Morris SB; Gummo CL; Keh CE; Hill AN; Thomas A; Macaraig M; St John K; J Ampie T; Chuck C; Burzynski J
Am J Public Health; 2020 Nov; 110(11):1696-1703. PubMed ID: 32941064
[No Abstract] [Full Text] [Related]
2. Enhancing management of tuberculosis treatment with video directly observed therapy in New York City.
Chuck C; Robinson E; Macaraig M; Alexander M; Burzynski J
Int J Tuberc Lung Dis; 2016 May; 20(5):588-93. PubMed ID: 27084810
[TBL] [Abstract][Full Text] [Related]
3. Tuberculosis Treatment Monitoring by Video Directly Observed Therapy in 5 Health Districts, California, USA.
Garfein RS; Liu L; Cuevas-Mota J; Collins K; Muñoz F; Catanzaro DG; Moser K; Higashi J; Al-Samarrai T; Kriner P; Vaishampayan J; Cepeda J; Bulterys MA; Martin NK; Rios P; Raab F
Emerg Infect Dis; 2018 Oct; 24(10):1806-1815. PubMed ID: 30226154
[TBL] [Abstract][Full Text] [Related]
4. Using Video Technology to Increase Treatment Completion for Patients With Latent Tuberculosis Infection on 3-Month Isoniazid and Rifapentine: An Implementation Study.
Lam CK; McGinnis Pilote K; Haque A; Burzynski J; Chuck C; Macaraig M
J Med Internet Res; 2018 Nov; 20(11):e287. PubMed ID: 30459146
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of tuberculosis treatment monitoring by video directly observed therapy: a binational pilot study.
Garfein RS; Collins K; Muñoz F; Moser K; Cerecer-Callu P; Raab F; Rios P; Flick A; Zúñiga ML; Cuevas-Mota J; Liang K; Rangel G; Burgos JL; Rodwell TC; Patrick K
Int J Tuberc Lung Dis; 2015 Sep; 19(9):1057-64. PubMed ID: 26260824
[TBL] [Abstract][Full Text] [Related]
6. Real-world implementation of video-observed therapy in an urban TB program in the United States.
Perry A; Chitnis A; Chin A; Hoffmann C; Chang L; Robinson M; Maltas G; Munk E; Shah M
Int J Tuberc Lung Dis; 2021 Aug; 25(8):655-661. PubMed ID: 34330351
[TBL] [Abstract][Full Text] [Related]
7. Telemedicine Technologies and Tuberculosis Management: A Randomized Controlled Trial.
Guo P; Qiao W; Sun Y; Liu F; Wang C
Telemed J E Health; 2020 Sep; 26(9):1150-1156. PubMed ID: 31794684
[No Abstract] [Full Text] [Related]
8. Cost comparison of wirelessly vs. directly observed therapy for adherence confirmation in anti-tuberculosis treatment.
Au-Yeung KY; DiCarlo L
Int J Tuberc Lung Dis; 2012 Nov; 16(11):1498-504. PubMed ID: 23006834
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for Use of Video Directly Observed Therapy During Tuberculosis Treatment - United States, 2023.
Mangan JM; Woodruff RS; Winston CA; Nabity SA; Haddad MB; Dixon MG; Parvez FM; Sera-Josef C; Salmon-Trejo LAT; Lam CK
MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(12):313-316. PubMed ID: 36952279
[TBL] [Abstract][Full Text] [Related]
10. Cost savings associated with video directly observed therapy for treatment of tuberculosis.
Lam CK; Fluegge K; Macaraig M; Burzynski J
Int J Tuberc Lung Dis; 2019 Nov; 23(11):1149-1154. PubMed ID: 31718750
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of recorded video-observed therapy for anti-tuberculosis treatment.
Garfein RS; Liu L; Cuevas-Mota J; Collins K; Catanzaro DG; Muñoz F; Moser K; Chuck C; Higashi J; Bulterys MA; Raab F; Rios P
Int J Tuberc Lung Dis; 2020 May; 24(5):520-525. PubMed ID: 32398202
[No Abstract] [Full Text] [Related]
12. Tuberculosis treatment adherence in the era of COVID-19.
Lippincott CK; Perry A; Munk E; Maltas G; Shah M
BMC Infect Dis; 2022 Oct; 22(1):800. PubMed ID: 36289485
[TBL] [Abstract][Full Text] [Related]
13. Stakeholders' Perceptions of Benefits of and Barriers to Using Video-Observed Treatment for Monitoring Patients With Tuberculosis in Uganda: Exploratory Qualitative Study.
Sekandi JN; Kasiita V; Onuoha NA; Zalwango S; Nakkonde D; Kaawa-Mafigiri D; Turinawe J; Kakaire R; Davis-Olwell P; Atuyambe L; Buregyeya E
JMIR Mhealth Uhealth; 2021 Oct; 9(10):e27131. PubMed ID: 34704961
[TBL] [Abstract][Full Text] [Related]
14. Requiring smartphone ownership for mHealth interventions: who could be left out?
Bommakanti KK; Smith LL; Liu L; Do D; Cuevas-Mota J; Collins K; Munoz F; Rodwell TC; Garfein RS
BMC Public Health; 2020 Jan; 20(1):81. PubMed ID: 31959145
[TBL] [Abstract][Full Text] [Related]
15. Advancing Patient-Centered Care in Tuberculosis Management: A Mixed-Methods Appraisal of Video Directly Observed Therapy.
Holzman SB; Zenilman A; Shah M
Open Forum Infect Dis; 2018 Apr; 5(4):ofy046. PubMed ID: 29732378
[TBL] [Abstract][Full Text] [Related]
16. Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial.
Browne SH; Umlauf A; Tucker AJ; Low J; Moser K; Gonzalez Garcia J; Peloquin CA; Blaschke T; Vaida F; Benson CA
PLoS Med; 2019 Oct; 16(10):e1002891. PubMed ID: 31584944
[TBL] [Abstract][Full Text] [Related]
17. Tele-TB: Using TeleMedicine to Increase Access to Directly Observed Therapy for Latent Tuberculosis Infection.
Donahue ML; Eberly MD; Rajnik M
Mil Med; 2021 Jan; 186(Suppl 1):25-31. PubMed ID: 33499464
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and acceptability pilot of video-based direct observed treatment (vDOT) for supporting antitubercular treatment in South India: a cohort study.
Rodrigues R; Varghese SS; Mahrous M; Ananthaneni Kumar A; Ahmed MN; D'Souza G
BMJ Open; 2023 May; 13(5):e065878. PubMed ID: 37247959
[TBL] [Abstract][Full Text] [Related]
19. Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.
Manyazewal T; Woldeamanuel Y; Holland DP; Fekadu A; Blumberg HM; Marconi VC
Trials; 2020 May; 21(1):383. PubMed ID: 32370774
[TBL] [Abstract][Full Text] [Related]
20. In-Person vs Electronic Directly Observed Therapy for Tuberculosis Treatment Adherence: A Randomized Noninferiority Trial.
Burzynski J; Mangan JM; Lam CK; Macaraig M; Salerno MM; deCastro BR; Goswami ND; Lin CY; Schluger NW; Vernon A;
JAMA Netw Open; 2022 Jan; 5(1):e2144210. PubMed ID: 35050357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
